Get started
MarketMoversReport

Zynerba Pharmaceuticals Announces Positive Top Line Results

Long
MarketMoversReport  
NASDAQ:ZYNE   None
Beyond Technical Analysis
1
0
beyondta
ZYNE: Zynerba Pharmaceuticals, Inc.
2022-06-22 20:05:00
Zynerba Pharmaceuticals Announces Positive Top Line Results from Open-Label Phase 2 INSPIRE Trial of Zygel™ in 22q11.2 Deletion Syndrome
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.